https://www.selleckchem.com/products/a-196.html
7%, 2019 2.8%; β -0.64 [95% CI -0.69 to -0.59]; p .001) decreased in diabetic PAD patients during the observational time. In spite of improved morbidity and mortality in the last years of the observational period, patients with DM still suffered from an increased risk for morbidity and mortality during the observational period compared to nondiabetic PAD patients. Despite the progress in DM treatments, DM still was associated with an unfavorable clinical patient profile and remained a substantial risk factor for morbidity and mortali
Like
Comment
Share
